Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, serum concentrations and
pharmacodynamic effects on serum low-density lipoprotein (LDL) cholesterol of single and
multiple subcutaneous and intravenous doses of BMS-844421 in healthy subjects (SAD) and in
subjects with elevated cholesterol (MAD).